PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 121 filers reported holding PUMA BIOTECHNOLOGY INC in Q2 2021. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $0 | – | 14 | -94.9% | 0.00% | – |
| Q3 2022 | $0 | – | 275 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | – | 275 | 0.0% | 0.00% | – |
| Q1 2022 | $0 | – | 275 | 0.0% | 0.00% | – |
| Q4 2021 | $0 | -100.0% | 275 | -79.2% | 0.00% | – |
| Q3 2021 | $9,000 | -98.3% | 1,323 | -97.7% | 0.00% | -100.0% |
| Q2 2021 | $524,000 | +52300.0% | 57,102 | +36270.7% | 0.00% | – |
| Q3 2020 | $1,000 | 0.0% | 157 | +58.6% | 0.00% | – |
| Q2 2020 | $1,000 | 0.0% | 99 | -39.3% | 0.00% | – |
| Q1 2020 | $1,000 | -98.1% | 163 | -96.7% | 0.00% | -100.0% |
| Q3 2019 | $53,000 | -13.1% | 4,900 | +2.1% | 0.00% | 0.0% |
| Q2 2019 | $61,000 | -67.2% | 4,800 | 0.0% | 0.00% | -66.7% |
| Q1 2019 | $186,000 | +89.8% | 4,800 | 0.0% | 0.00% | +50.0% |
| Q4 2018 | $98,000 | – | 4,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 200,000 | $20,706,000 | 6.01% |
| Redmile Group, LLC | 230,673 | $23,882,000 | 2.95% |
| WEATHERBIE CAPITAL, LLC | 241,419 | $24,994,000 | 2.31% |
| Tekla Capital Management LLC | 185,820 | $19,238,000 | 2.02% |
| Ghost Tree Capital, LLC | 25,000 | $2,588,000 | 1.59% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 5,686,668 | $588,741,000 | 1.56% |
| Iguana Healthcare Management, LLC | 25,000 | $2,588,000 | 1.48% |
| Eventide Asset Management | 42,100 | $4,359,000 | 1.34% |
| Bain Capital Public Equity Management, LLC | 401,330 | $41,550,000 | 1.17% |
| Rock Springs Capital Management LP | 31,500 | $3,261,000 | 1.16% |